Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
How 'overenthusiasm' led to Big Pharma's risky $6B TIGIT gamble
Once hailed as the future of immuno-oncology, it’s been a tough few months for any remaining fans of anti-TIGIT antibodies.
James Waldron
Jun 13, 2025 8:00am
AstraZeneca pens $5.3B pact with CSPC to develop oral drugs
Jun 13, 2025 5:56am
Fierce Pharma
Syntimmune shareholders win again over AZ, this time for $181M
Jun 12, 2025 11:40am
Guardant360-guided breast cancer therapy swaps boost survival
Jun 3, 2025 10:00am
AstraZeneca's breast cancer pill boosts PFS by 56% in phase 3
Jun 2, 2025 7:10am
Roche nets FDA breakthrough label for AI lung cancer CDx test
Apr 29, 2025 2:07pm
